Table 1.
The characteristics of subjects.
| ND AML patients (n = 49) | CR AML patients (n = 38) | Relapsed-refractory AML patients (n = 18) | Controls (n = 19) | |
|---|---|---|---|---|
| Age (years) | 21–83 | 19–71 | 18–63 | 18–67 |
| Gender (male/female) | 26/23 | 19/19 | 10/8 | 5/14 |
| WBC (∗109/L) | 31.06 ± 53.64 | 5.30 ± 2.13 | 40.12 ± 61.02 | 6.5274 ± 2.42 |
| BM leukemic blast (%) | 72.61 ± 40.91 | 1.17 ± 1.15 | 58.27 ± 29.13 | |
| FAB subtype | ||||
| M1 | 2 | 0 | 0 | |
| M2 | 7 | 2 | 1 | |
| M3 | 9 | 14 | 1 | |
| M4 | 9 | 9 | 5 | |
| M5 | 22 | 13 | 11 |
ND: newly diagnosed; CR: complete remission; WBC: white blood cell; FAB: French-American-British; BM: bone marrow.